HISTORICAL FACTS: Bristol myers squibb - The Untold Story

Bristol Myers Squibb Stock: Is Wall Street Bullish or Bearish?

Bristol Myers Squibb has outperformed the broader market, while analysts maintain a moderately optimistic outlook despite a more cautious earnings outlook.

Barchart · 6h ago

Artiva Ends AlloNK Autoimmune Cell Therapy After Two Trial Deaths, One Unexplained, and Cuts 94% of Staff

Artiva Biotherapeutics is ending development of AlloNK after two deaths in a Phase 2a autoimmune disease trial, cutting most of its workforce and reviewing strategic options.

Medical Daily · Oct 30

Anthropic Announced New Achievements in Drug Research and Lab Work. An Expert Says AI is 'Changing the Medical Field.'

Anthropic outlined collaborations with six organizations, including Bristol Myers Squibb, Generate Biomedicines and BigHat Biosciences.

International Business Times · Oct 29

Neuroendocrine Tumor Patients Whose Lutetium Therapy Stopped Working Saw Slower Progression on Actinium-Based RYZ101 in Phase 3 Trial

Bristol Myers Squibb says actinium-based RYZ101 improved progression-free survival in neuroendocrine tumors after lutetium therapy. Topline data are company-reported.

Medical Daily · Oct 15

Bristol Myers Pulmonary Fibrosis Drug Admilparant Met Main Goal at 60 mg, but Higher Dose Missed

BMS said Admilparant met its phase 3 goal in pulmonary fibrosis at 60 mg, but 120 mg missed. Data are topline. What patients and families should know.

Medical Daily · Oct 15

Andy Burnham announces £48m partnership in bid to find dementia cure

The Prime Minister, whose father Roy died last month after suffering from Alzheimer’s, said he wanted Britain ‘to be the country that makes the breakthrough’

The Independent UK · Oct 8

HRSA Names 10 Drugmakers and 21 Drugs for 340B Rebate Pilot as Hospitals Weigh Options Before January Launch

HRSA approved 10 drugmakers and 21 drugs, including Eliquis and Jardiance, for its 340B rebate pilot starting Jan. 1 as hospitals weigh legal options.

Medical Daily · Oct 5

Teens with Obstructive Hypertrophic Cardiomyopathy Gain Their First FDA-Approved Treatment as Camzyos Approval Expands Beyond Adults

FDA approved Camzyos for children 66 pounds or more with obstructive HCM, the first treatment for this group, based on a 44-patient trial.

Medical Daily · Oct 5

IAS 2026 in Review: The Biggest Signals From Rio, and What They Mean for the Next Decade of HIV Research and Treatment

Rio de Janeiro hosted AIDS 2026, the 26th International AIDS Conference, from July 26 to 31, drawing roughly 7,000 delegates under the theme "Rethink. Rebuild. Rise." Coverage is divided into two parallel stories: one about some of the most important scientific progress the HIV field has made in years, and…

Medical Daily · Sep 23

Two Drugmakers Have Paused Autoimmune CAR T Cell Trials After Three Deaths from a Severe Immune Reaction

Novartis paused eight autoimmune CAR T trials after three severe immune reactions, and Bristol Myers Squibb paused enrollment in its program.

Medical Daily · Sep 2